Ikuo Kamitsukasa Selected Research

Ikuo Kamitsukasa Research Topics

Disease

5	Transient Ischemic Attack 07/2021 - 01/2018
4	Cerebral Infarction 07/2021 - 01/2016
4	Atherosclerosis 01/2021 - 01/2016
3	Diabetes Mellitus 01/2021 - 01/2016
3	Ischemic Stroke 01/2021 - 07/2015
2	Syncope (Fainting) 06/2021 - 07/2015
1	Hiccup (Hiccups) 06/2021
1	Vomiting 06/2021
1	Nausea 06/2021
1	Orthostatic Hypotension (Postural Hypotension) 06/2021
1	Chronic Renal Insufficiency 01/2021
1	Myocardial Infarction 01/2021
1	Esophageal Squamous Cell Carcinoma 12/2020
1	Neoplasms (Cancer) 12/2020
1	Colorectal Neoplasms (Colorectal Cancer) 12/2020
1	Acute Coronary Syndrome 08/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2018
1	Headache (Headaches) 09/2017
1	Rheumatoid Arthritis 09/2017
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 09/2017
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2016
1	Stroke (Strokes) 07/2015
1	Skin Manifestations 07/2015
1	Acute Pain 07/2015
1	Meningitis 12/2014
1	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 12/2014
1	Myoclonus (Nocturnal Myoclonus) 02/2014
1	Encephalitis (Encephalitis, Rasmussen) 01/2014
1	Respiratory Insufficiency (Respiratory Failure) 05/2012
1	Heart Failure 05/2012
1	Alcoholism (Alcohol Abuse) 02/2012
1	Renal Tubular Acidosis (Distal Renal Tubular Acidosis) 02/2012
1	Diarrhea 02/2012
1	Hyperaldosteronism (Conn Syndrome) 02/2012
1	Paralysis (Palsy) 02/2012
1	Ventricular Fibrillation 02/2012
1	Liddle Syndrome 02/2012
1	Pellagra 06/2011
1	Thiamine Deficiency 06/2011
1	Laryngitis 06/2011
1	Glossitis 06/2011
1	Avitaminosis (Vitamin Deficiency) 06/2011
1	Psychotic Disorders (Schizoaffective Disorder) 06/2011
1	Neuroaspergillosis 01/2009
1	Aspergillosis 01/2009
1	Blood Vessel Dissection 08/2008
1	Enteritis 12/2002
1	Progressive Bulbar Palsy (Fazio Londe Syndrome) 12/2002
1	Guillain-Barre Syndrome 12/2002

Drug/Important Bio-Agent (IBA)

3	AntibodiesIBA 07/2021 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2020
2	Complementary DNA (cDNA)IBA 01/2021 - 12/2020
2	Immunoglobulin G (IgG)IBA 01/2021 - 12/2002
2	AntigensIBA 01/2021 - 12/2020
2	Biomarkers (Surrogate Marker)IBA 12/2020 - 08/2020
1	hydroxide ionIBA 06/2021
1	Peptides (Polypeptides)IBA 01/2021
1	ImmunosorbentsIBA 01/2021
1	Recombinant ProteinsIBA 01/2021
1	AutoantibodiesIBA 02/2018
1	Pharmaceutical PreparationsIBA 09/2017
1	Atovaquone (Mepron)FDA Link 09/2017
1	AdiponectinIBA 01/2016
1	Adenosine DeaminaseIBA 12/2014
1	BenzodiazepinesIBA 02/2014
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 01/2014
1	ConvulsantsIBA 05/2012
1	Creatine Kinase (Creatine Phosphokinase)IBA 02/2012
1	PotassiumIBA 02/2012
1	Thiamine (Aneurin)FDA Link 06/2011
1	Niacinamide (Nicotinamide)FDA LinkGeneric 06/2011
1	Niacin (Nicotinic Acid)FDA LinkGeneric 06/2011
1	mecobalamin (methylcobalamin)IBA 06/2011
1	Pyridoxine (Pyridoxin)FDA LinkGeneric 06/2011
1	Voriconazole (Vfend)FDA LinkGeneric 01/2009
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2009
1	CarbonatesIBA 08/2008

Therapy/Procedure

2	Therapeutics 07/2015 - 06/2011
1	Aftercare (After-Treatment) 06/2011